
Nevalto5 mg+80 mg
Beximco Pharmaceuticals Ltd.
Nebivolol + Valsartan is a fixed-dose combination antihypertensive approved for the treatment of hypertension (high blood pressure) in adults.
Nebivolol + Valsartan is a fixed-dose combination antihypertensive approved for the treatment of hypertension (high blood pressure) in adults.
| Indication | Recommended Dose | Notes |
|---|---|---|
| Hypertension, add-on therapy | One tablet (typically nebivolol 5 mg / valsartan 80 mg) orally once daily | Maximum blood pressure-lowering effect is generally seen within 2 weeks; the fixed-dose tablet should not be split. |
Dose adjustment of the individual components is not possible with the fixed-dose tablet; if a different ratio of nebivolol to valsartan is required, the individual single-ingredient medicines should be used instead, as directed by a physician. See Use in Special Populations for renal and hepatic dosing considerations.
Most patients tolerate Nebivolol + Valsartan well. Reported side effects include:
Nebivolol + Valsartan is contraindicated in patients with:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.